Selective and effective: silicon nanowires as photoelectrodes for carbon dioxide fixation

June 12, 2012
Selective and effective: silicon nanowires as photoelectrodes for carbon dioxide fixation

( -- During photosynthesis, plants capture solar energy and use it to drive chemical reactions. Their carbon source is the CO2 in air. In the journal Angewandte Chemie, American scientists have now proposed a new reaction mechanism that binds CO2 and strongly resembles photosynthesis. In this process, light energy is captured by silicon nanowires. It was successfully used to synthesize two precursors of the anti-inflammatory, pain reducing drugs ibuprofen and naproxen.

Natural photosynthesis involves two processes, the light and dark reactions. In the light reactions, photons are captured and their energy stored in the form of like NADPH (nicotinamide adenine dinucleotide phosphate) and ATP (adenosine triphosphate), which subsequently are used to bind CO2 for the synthesis of complex . At the heart of the dark reactions is the binding of CO2 to a sugar phosphate (ribulose-1,5-bisphosphate). This results in formation of a β–keto acid, which gets converted to a central building block for sugar synthesis.

A team led by Kian L. Tan and Dunwei Wang at Boston College (Chestnut Hill, USA) has been inspired by the mechanisms of the dark reactions. To capture sunlight, the scientists used p-doped silicon nanowires as a photocathode. These very effectively convert solar energy to electrical energy, are easy to produce, and are amazingly stable under the reaction conditions needed. Captured photons release electrons from the atoms in the . These electrons can easily be transferred to organic molecules to trigger chemical reactions. The researchers chose aromatic ketones as their starting materials. Transfer of electrons from the photocathode “activates” these molecules so that they can attack and bind CO2. Over several steps, the reaction produces an α-hydroxy acid. This allowed the team to produce precursors of ibuprofen and naproxen with high selectivity and in high yield.

This reaction sequence closely resembles natural photosynthesis and is completely different from previous approaches to binding CO2 with the aid of sunlight. This finally solves a problem: The very poor selectivity that automatically accompanies all traditional attempts at the direct photoreduction of CO2 has limited previous methods to the production of fuels. This new strategy delivers the selectivity required for the production of complex organic intermediates for the production of pharmaceuticals and high-value fine chemicals.

Explore further: MIT researchers harness the sun's power

More information: by Dunwei Wang, Silicon Nanowires as Photoelectrodes for Carbon Dioxide Fixation, Angewandte Chemie International Edition, Permalink to the article:

Related Stories

MIT researchers harness the sun's power

May 12, 2010

For decades, scientists have been trying to replicate the process of photosynthesis -- the process by which plants convert sunlight into energy. The Economist reports that Angela Belcher and her colleagues at the Massachusetts ...

Modified microbes turn carbon dioxide to liquid fuel

March 29, 2012

Imagine being able to use electricity to power your car — even if it's not an electric vehicle. Researchers at the UCLA Henry Samueli School of Engineering and Applied Science have for the first time demonstrated a method ...

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Getting under the skin of a medieval mystery

November 23, 2015

A simple PVC eraser has helped an international team of scientists led by bioarchaeologists at the University of York to resolve the mystery surrounding the tissue-thin parchment used by medieval scribes to produce the first ...

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.